Equities
Health CarePharmaceuticals and Biotechnology
  • Price (USD)57.10
  • Today's Change0.24 / 0.42%
  • Shares traded1.62m
  • 1 Year change-11.54%
  • Beta0.7391
Data delayed at least 15 minutes, as of May 17 2024 21:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments3,6563,2392,348
Total Receivables, Net744645616
Total Inventory634228
Prepaid expenses183167126
Other current assets, total------
Total current assets4,6454,0933,119
Property, plant & equipment, net777766751
Goodwill, net156156156
Intangibles, net124129151
Long term investments188134221
Note receivable - long term------
Other long term assets25910466
Total assets6,7825,8414,933
LIABILITIES
Accounts payable110278172
Accrued expenses736576460
Notes payable/short-term debt000
Current portion long-term debt/capital leases3.443.182.64
Other current liabilities, total392301219
Total current liabilities1,2401,157854
Total long term debt293032
Total debt333334
Deferred income tax------
Minority interest------
Other liabilities, total323284277
Total liabilities1,5921,4711,163
SHAREHOLDERS EQUITY
Common stock0.220.220.22
Additional paid-in capital5,0164,7924,567
Retained earnings (accumulated deficit)160(437)(778)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total1315(19)
Total equity5,1904,3703,770
Total liabilities & shareholders' equity6,7825,8414,933
Total common shares outstanding224223221
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.